{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:26:38Z","timestamp":1790742398164,"version":"4.1.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.hlc.2022.04.056","type":"journal-article","created":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:36:49Z","timestamp":1654303009000},"page":"1191-1202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Portopulmonary Hypertension: A Review of the Current Literature"],"prefix":"10.1016","volume":"31","author":[{"given":"Spyros","family":"Peppas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6230-7214","authenticated-orcid":false,"given":"Sanjana","family":"Nagraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Koutsias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Kladas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-6916","authenticated-orcid":false,"given":"Paraschos","family":"Archontakis-Barakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-0112","authenticated-orcid":false,"given":"Dimitrios","family":"Schizas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-6319","authenticated-orcid":false,"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-5991","authenticated-orcid":false,"given":"Leonidas","family":"Palaiodimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damianos G.","family":"Kokkinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0032-1301731","article-title":"Portopulmonary hypertension","volume":"33","author":"Krowka","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.04.00010904","article-title":"Pulmonary-hepatic vascular disorders (PHD)","volume":"24","author":"Rodr\u00edguez-Roisin","year":"2004","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","article-title":"Portopulmonary hypertension: survival and prognostic factors","volume":"178","author":"Le Pavec","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"9419","key":"10.1016\/j.hlc.2022.04.056_bib4","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(04)16107-2","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome","volume":"363","author":"Hoeper","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib5","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.hlc.2022.04.056_bib6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3748\/wjg.v24.i12.1285","article-title":"Review article: update on current and emergent data on hepatopulmonary syndrome","volume":"24","author":"Soulaidopoulos","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.hlc.2022.04.056_bib7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International Liver Transplant Society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11894-016-0504-2","article-title":"Current approach to the diagnosis and management of portopulmonary hypertension","volume":"18","author":"Fussner","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"issue":"11","key":"10.1016\/j.hlc.2022.04.056_bib9","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/imj.14751","article-title":"Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry","volume":"51","author":"Lazaro Salvador","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.hlc.2022.04.056_bib11","doi-asserted-by":"crossref","first-page":"569413","DOI":"10.3389\/fmed.2020.569413","article-title":"Portopulmonary hypertension: from bench to bedside","volume":"7","author":"Thomas","year":"2020","journal-title":"Front Med"},{"issue":"9","key":"10.1016\/j.hlc.2022.04.056_bib12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.hlc.2022.04.056_bib13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.healun.2016.12.014","article-title":"Survival in portopulmonary hypertension: outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry","volume":"36","author":"Sithamparanathan","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the US-based REVEAL Registry","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.00101211","article-title":"Survival in pulmonary hypertension in Spain: insights from the Spanish registry","volume":"40","author":"Escribano-Subias","year":"2012","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.hlc.2022.04.056_bib16","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1164\/rccm.201203-0383OC","article-title":"Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland","volume":"186","author":"Ling","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/etm.2013.918","article-title":"Portopulmonary hypertension in cirrhotic patients: prevalence, clinical features and risk factors","volume":"5","author":"Chen","year":"2013","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4065\/71.6.543","article-title":"Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients","volume":"71","author":"Castro","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jhep.2003.50060","article-title":"Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study","volume":"37","author":"Colle","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/lt.500030503","article-title":"Severe pulmonary hypertension in liver transplant candidates","volume":"3","author":"Ramsay","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib23","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary hypertension: results from a 10-year screening algorithm","volume":"44","author":"Krowka","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2022.04.056_bib24","first-page":"9629570","article-title":"Prevalence and prognosis of portopulmonary hypertension in 223 liver transplant recipients","volume":"2018","author":"Li","year":"2018","journal-title":"Can Respir J"},{"issue":"9","key":"10.1016\/j.hlc.2022.04.056_bib25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/gut.52.9.1355","article-title":"Portopulmonary hypertension in decompensated cirrhosis with refractory ascites","volume":"52","author":"Benjaminov","year":"2003","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.hlc.2022.04.056_bib27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/lt.20459","article-title":"Hemodynamics and survival of patients with portopulmonary hypertension","volume":"11","author":"Kawut","year":"2005","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib28","first-page":"849","article-title":"Pulmonary hypertension complicating portal hypertension","volume":"120","author":"Lebrec","year":"1979","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.CIR.37.1.88","article-title":"Pulmonary hypertension associated with cirrhosis of the liver and with portacaval shunts","volume":"37","author":"Senior","year":"1968","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/jcp.46.3.222","article-title":"Pulmonary platelet aggregates: possible cause of sudden peroperative death in adults undergoing liver transplantation","volume":"46","author":"Sankey","year":"1993","journal-title":"J\u00a0Clin Pathol"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib31","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0735-1097(87)80123-7","article-title":"Coexistent pulmonary and portal hypertension: morphologic and clinical features","volume":"10","author":"Edwards","year":"1987","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2022.04.056_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.CIR.22.3.376","article-title":"\u201cPrimary\u201d pulmonary hypertension with coexisting portal hypertension. A retrospective study of six cases","volume":"22","author":"Naeye","year":"1960","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/lt.500060209","article-title":"A\u00a0spectrum of pulmonary vascular pathology in portopulmonary hypertension","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1378\/chest.123.2.562","article-title":"Portopulmonary hypertension: a tale of two circulations","volume":"123","author":"Budhiraja","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0037-1606251","article-title":"Portopulmonary hypertension","volume":"38","author":"Savale","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0272-5231(05)70305-1","article-title":"Mediators, cytokines, and growth factors in liver-lung interactions","volume":"17","author":"Panos","year":"1996","journal-title":"Clin Chest Med"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3748\/wjg.v12.i6.837","article-title":"Cardiac and vascular changes in cirrhosis: pathogenic mechanisms","volume":"12","author":"Liu","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib38","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1053\/j.gastro.2011.06.053","article-title":"Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment","volume":"141","author":"Talwalkar","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib39","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.26745","article-title":"Pulmonary complications in chronic liver disease","volume":"59","author":"Machicao","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib40","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/liv.12791","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment","volume":"35","author":"Raevens","year":"2015","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib41","first-page":"309","article-title":"Portopulmonary hypertension in cirrhosis: the pathogenetic challenge","volume":"54","author":"Wong","year":"2005","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib42","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0735-1097(10)80121-4","article-title":"Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations","volume":"17","author":"Robalino","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib43","doi-asserted-by":"crossref","first-page":"1700745","DOI":"10.1183\/13993003.00745-2017","article-title":"Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: highlights from basic research to therapy","volume":"51","author":"Huertas","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib44","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1378\/chest.115.6.1708","article-title":"Alpha1-adrenergic hypothesis for pulmonary hypertension","volume":"115","author":"Salvi","year":"1999","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12328-019-00956-0","article-title":"Vascular syndromes in liver cirrhosis","volume":"12","author":"Shenoda","year":"2019","journal-title":"Clin J Gastroenterol"},{"issue":"7","key":"10.1016\/j.hlc.2022.04.056_bib46","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/00365521.2016.1157895","article-title":"Portopulmonary hypertension","volume":"51","author":"Lv","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"25","key":"10.1016\/j.hlc.2022.04.056_bib47","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.3748\/wjg.v20.i25.8072","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome","volume":"20","author":"Aldenkortt","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"16","key":"10.1016\/j.hlc.2022.04.056_bib48","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1177\/1535370220949148","article-title":"Endothelin-1 in portal hypertension: the intricate role of hepatic stellate cells","volume":"245","author":"Ezhilarasan","year":"2020","journal-title":"Exp Biol Med"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5604\/16652681.1198799","article-title":"Angiogenesis and portal-systemic collaterals in portal hypertension","volume":"15","author":"Gana","year":"2016","journal-title":"Ann Hepatol"},{"issue":"9368","key":"10.1016\/j.hlc.2022.04.056_bib50","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0140-6736(03)13167-4","article-title":"Primary pulmonary hypertension","volume":"361","author":"Runo","year":"2003","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.hlc.2022.04.056_bib51","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/01.CIR.94.7.1578","article-title":"Human pulmonary circulation is an important site for both clearance and production of endothelin-1","volume":"94","author":"Dupuis","year":"1996","journal-title":"Circulation"},{"issue":"Suppl 3","key":"10.1016\/j.hlc.2022.04.056_bib52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2362.2006.01690.x","article-title":"Endothelin and endothelin receptor antagonism in portopulmonary hypertension","volume":"36","author":"Neuhofer","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"10.1016\/j.hlc.2022.04.056_bib53","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/gut.2005.088633","article-title":"Role of endothelin in systemic and portal resistance in cirrhosis","volume":"55","author":"Angus","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/jhep.2003.50044","article-title":"Vascular mediators in the injured liver","volume":"37","author":"Rockey","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib55","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1139\/y03-008","article-title":"The endothelin system in pulmonary hypertension","volume":"81","author":"Michel","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib56","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1183\/09031936.05.00080804","article-title":"Bosentan therapy for portopulmonary hypertension","volume":"25","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.10-0574","article-title":"Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension","volume":"139","author":"Cartin-Ceba","year":"2011","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.hlc.2022.04.056_bib58","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib59","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2006.02.013","article-title":"Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M","volume":"45","author":"Tazi","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.hlc.2022.04.056_bib61","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/0003319710369101","article-title":"Plasma cytokines and portopulmonary hypertension in patients with cirrhosis waiting for orthotopic liver transplantation","volume":"61","author":"Pellicelli","year":"2010","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib62","doi-asserted-by":"crossref","first-page":"1801899","DOI":"10.1183\/13993003.01899-2018","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"53","author":"Morrell","year":"2019","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib63","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1378\/chest.08-1909","article-title":"Serotonin transporter polymorphisms in patients with portopulmonary hypertension","volume":"135","author":"Roberts","year":"2009","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.hlc.2022.04.056_bib64","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","article-title":"Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension","volume":"108","author":"Eddahibi","year":"2001","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.hlc.2022.04.056_bib65","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200809-1472OC","article-title":"Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease","volume":"179","author":"Roberts","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.hlc.2022.04.056_bib66","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/rccm.201807-1236OC","article-title":"Bone morphogenetic protein 9 is a mechanistic biomarker of portopulmonary hypertension","volume":"199","author":"Nikolic","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.hlc.2022.04.056_bib67","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1164\/rccm.201912-2514LE","article-title":"BMP9\/10 in pulmonary vascular complications of liver disease","volume":"201","author":"Rochon","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib68","first-page":"237","article-title":"Pulmonary manifestations of chronic liver disease: a comprehensive review","volume":"33","author":"Soulaidopoulos","year":"2020","journal-title":"Ann Gastroenterol"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib69","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cld.2019.06.003","article-title":"Pulmonary complications of portal hypertension","volume":"23","author":"Cartin-Ceba","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"125","key":"10.1016\/j.hlc.2022.04.056_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1183\/09059180.00007211","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview","volume":"21","author":"Porres-Aguilar","year":"2012","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11894-009-0009-3","article-title":"Portopulmonary hypertension","volume":"11","author":"Nayak","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s005350170126","article-title":"Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations","volume":"36","author":"Yang","year":"2001","journal-title":"J\u00a0Gastroenterol"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib73","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1378\/chest.112.4.980","article-title":"Distinctive clinical features of portopulmonary hypertension","volume":"112","author":"Kuo","year":"1997","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib74","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CRD.0000000000000195","article-title":"Diagnosis, treatment, and management of orthotopic liver transplant candidates with portopulmonary hypertension","volume":"26","author":"Koulava","year":"2018","journal-title":"Cardiol Rev"},{"issue":"7","key":"10.1016\/j.hlc.2022.04.056_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13585","article-title":"Noninvasive estimation of pulmonary vascular resistance improves portopulmonary hypertension screening in liver transplant candidates","volume":"33","author":"DesJardin","year":"2019","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib78","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/lt.23870","article-title":"Long-term follow-up of portopulmonary hypertension patients after liver transplantation","volume":"20","author":"Khaderi","year":"2014","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4250\/jcvi.2018.26.e2","article-title":"Correlation between echocardiographic pulmonary artery pressure estimates and right heart catheterization measurement in liver transplant candidates","volume":"26","author":"Habash","year":"2018","journal-title":"J\u00a0Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib80","first-page":"157","article-title":"Role of 2-dimensional Doppler echo-cardiography in screening portopulmonary hypertension in portal hypertension patients","volume":"8","author":"Hua","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"11","key":"10.1016\/j.hlc.2022.04.056_bib81","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1053\/jlts.2002.35554","article-title":"Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates","volume":"8","author":"Cotton","year":"2002","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib82","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/jlts.2000.7573","article-title":"Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates","volume":"6","author":"Kim","year":"2000","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.hlc.2022.04.056_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13995","article-title":"Performance of echocardiography for detection of portopulmonary hypertension among liver transplant candidates: meta-analysis","volume":"34","author":"Korbitz","year":"2020","journal-title":"Clin Transplant"},{"issue":"13","key":"10.1016\/j.hlc.2022.04.056_bib84","article-title":"Lack of a tricuspid regurgitation Doppler signal and pulmonary hypertension by invasive measurement","volume":"7","author":"O\u2019Leary","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.hlc.2022.04.056_bib85","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.jacc.2006.07.061","article-title":"Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers","volume":"48","author":"Hoeper","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib86","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/lt.23649","article-title":"Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values","volume":"19","author":"Raevens","year":"2013","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib87","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00007890-200102270-00015","article-title":"Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates","volume":"71","author":"Torregrosa","year":"2001","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.hlc.2022.04.056_bib88","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/01.tp.0000235520.37189.fe","article-title":"Portopulmonary hypertension in the early phase following liver transplantation","volume":"82","author":"Saner","year":"2006","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.hlc.2022.04.056_bib89","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s00330-014-3289-4","article-title":"Portopulmonary hypertension: improved detection using CT and echocardiography in combination","volume":"24","author":"Devaraj","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.hlc.2022.04.056_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12659\/AOT.889645","article-title":"Prevalence of portopulmonary hypertension among liver transplant candidates in a region highly endemic for viral hepatitis","volume":"19","author":"Al-Harbi","year":"2014","journal-title":"Ann Transplant"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib91","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/heartjnl-2015-307786","article-title":"Right heart catheterisation: indications and interpretation","volume":"102","author":"Callan","year":"2016","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib92","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.00074312","article-title":"The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease","volume":"41","author":"Naeije","year":"2013","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib93","doi-asserted-by":"crossref","first-page":"1800332","DOI":"10.1183\/13993003.00332-2018","article-title":"ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension","volume":"53","author":"Gr\u00fcnig","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib94","first-page":"CD011285","article-title":"Exercise-based rehabilitation programmes for pulmonary hypertension","volume":"1","author":"Morris","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hlc.2022.04.056_bib95","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijcard.2018.08.085","article-title":"General measures and supportive therapy for pulmonary arterial hypertension: updated recommendations from the Cologne Consensus Conference 2018","volume":"272S","author":"Gr\u00fcnig","year":"2018","journal-title":"Int J Cardiol"},{"issue":"169","key":"10.1016\/j.hlc.2022.04.056_bib96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1742-1241.2010.02600.x","article-title":"Current management approaches to portopulmonary hypertension","author":"Savale","year":"2011","journal-title":"Int J Clin Pract Suppl"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib97","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib98","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/lt.20016","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database","volume":"10","author":"Krowka","year":"2004","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib99","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.30197","article-title":"Treatment barriers in portopulmonary hypertension","volume":"69","author":"AbuHalimeh","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib100","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/hep.31164","article-title":"Vasomodulators and liver transplantation for portopulmonary hypertension: evidence from a systematic review and meta-analysis","volume":"72","author":"Deroo","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib101","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2022.04.056_bib102","doi-asserted-by":"crossref","first-page":"528783","DOI":"10.1155\/2014\/528783","article-title":"Effect of PAH specific therapy on pulmonary hemodynamics and six-minute walk distance in portopulmonary hypertension: a systematic review and meta-analysis","volume":"2014","author":"Faisal","year":"2014","journal-title":"Pulm Med"},{"issue":"12","key":"10.1016\/j.hlc.2022.04.056_bib103","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11906-017-0796-0","article-title":"What is the role of oral prostacyclin pathway medications in pulmonary arterial hypertension management?","volume":"19","author":"El Yafawi","year":"2017","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib104","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A\u00a0comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension","volume":"338","author":"McLaughlin","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib106","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/lt.21174","article-title":"Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol","volume":"13","author":"Fix","year":"2007","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.hlc.2022.04.056_bib107","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1600-6143.2006.01432.x","article-title":"Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series","volume":"6","author":"Sussman","year":"2006","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib108","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1600-6143.2006.01701.x","article-title":"The impact of treatment of portopulmonary hypertension on survival following liver transplantation","volume":"7","author":"Ashfaq","year":"2007","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib109","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.510300307","article-title":"Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension","volume":"30","author":"Krowka","year":"1999","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib110","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00408-013-9501-5","article-title":"Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center\u2019s experience","volume":"191","author":"Awdish","year":"2013","journal-title":"Lung"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib111","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/lt.21997","article-title":"Acute and long-term effects of inhaled iloprost in portopulmonary hypertension","volume":"16","author":"Melgosa","year":"2010","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib112","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1183\/09031936.00032407","article-title":"Experience with inhaled iloprost and bosentan in portopulmonary hypertension","volume":"30","author":"Hoeper","year":"2007","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.hlc.2022.04.056_bib113","first-page":"1503","article-title":"Successful management of portopulmonary hypertension with beraprost","volume":"22","author":"Kim","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib114","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.11-2212","article-title":"Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and\/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial","volume":"142","author":"Tapson","year":"2012","journal-title":"Chest"},{"issue":"26","key":"10.1016\/j.hlc.2022.04.056_bib115","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib116","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018769305","article-title":"Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1\/-2 studies","volume":"8","author":"Cartin-Ceba","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.hlc.2022.04.056_bib117","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-3-642-38664-0_12","article-title":"Soluble guanylate cyclase stimulators in pulmonary hypertension","volume":"218","author":"Stasch","year":"2013","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib118","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1183\/09031936.00090614","article-title":"Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)","volume":"45","author":"Rubin","year":"2015","journal-title":"Eur Respir J"},{"issue":"20","key":"10.1016\/j.hlc.2022.04.056_bib119","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.21479","article-title":"Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation","volume":"15","author":"Hemnes","year":"2009","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib121","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccm.2013.09.005","article-title":"Oral therapies for pulmonary arterial hypertension: endothelin receptor antagonists and phosphodiesterase-5 inhibitors","volume":"34","author":"Channick","year":"2013","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib122","first-page":"15","article-title":"Oral therapies for pulmonary arterial hypertension: endothelin receptor antagonists and phosphodiesterase-5 inhibitors","volume":"15","author":"Hemnes","year":"2009","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib123","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/lt.21533","article-title":"Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension","volume":"15","author":"Gough","year":"2009","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib124","first-page":"42","article-title":"Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension","volume":"22","author":"Fisher","year":"2015","journal-title":"Can Respir J"},{"issue":"3","key":"10.1016\/j.hlc.2022.04.056_bib125","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1183\/09031936.06.00030206","article-title":"Sildenafil treatment for portopulmonary hypertension","volume":"28","author":"Reichenberger","year":"2006","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib126","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.transproceed.2019.01.139","article-title":"Sildenafil monotherapy to treat portopulmonary hypertension before liver transplant","volume":"51","author":"Cheng","year":"2019","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.hlc.2022.04.056_bib127","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/lt.23407","article-title":"Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension","volume":"18","author":"Hollatz","year":"2012","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.hlc.2022.04.056_bib128","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1183\/09031936.00117511","article-title":"Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension","volume":"41","author":"Savale","year":"2013","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib129","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healun.2019.12.008","article-title":"Ambrisentan in portopulmonary hypertension: a multicenter, open-label trial","volume":"39","author":"Preston","year":"2020","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.hlc.2022.04.056_bib130","first-page":"1258","article-title":"Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension","volume":"49","author":"Halank","year":"2011","journal-title":"Z\u00a0Gastroenterol"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib131","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jlts.2000.6356","article-title":"Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.hlc.2022.04.056_bib132","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.28990","article-title":"Long-term outcome in liver transplantation candidates with portopulmonary hypertension","volume":"65","author":"Savale","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.hlc.2022.04.056_bib133","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1213\/00000539-199610000-00003","article-title":"Moderate primary pulmonary hypertension in patients undergoing liver transplantation","volume":"83","author":"Taura","year":"1996","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.hlc.2022.04.056_bib134","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ACO.0b013e32833725c4","article-title":"Portopulmonary hypertension and right heart failure in patients with cirrhosis","volume":"23","author":"Ramsay","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"issue":"12 Suppl 3","key":"10.1016\/j.hlc.2022.04.056_bib135","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/lt.20979","article-title":"Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standa","volume":"12","author":"Freeman","year":"2006","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.hlc.2022.04.056_bib136","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/ajt.12783","article-title":"MELD exceptions for portopulmonary hypertension: current policy and future implementation","volume":"14","author":"Goldberg","year":"2014","journal-title":"Am J Transpl"},{"issue":"7","key":"10.1016\/j.hlc.2022.04.056_bib137","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/TP.0000000000001666","article-title":"Predictors of waitlist mortality in portopulmonary hypertension","volume":"101","author":"DuBrock","year":"2017","journal-title":"Transplantation"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622002025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622002025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:06:33Z","timestamp":1761415593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950622002025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":137,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1443950622002025"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2022.04.056","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Portopulmonary Hypertension: A Review of the Current Literature","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2022.04.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}